AUSTIN, Texas – MindWalk Holdings Corp. (Nasdaq: HYFT), a bio-native AI company, announced the appointment of R. Scott Areglado as Chief Financial Officer, effective October 20, 2025.
“Scott’s extensive experience leading financial strategy for high-growth, publicly traded healthcare and technology companies makes him an ideal addition to our executive team,” said Dr. Jennifer Bath, Chief Executive Officer of MindWalk. “His proven ability to strengthen financial systems, execute disciplined growth initiatives, and communicate effectively with the investment community will be instrumental as we scale our Bio-Native AI platform globally.”
Areglado brings more than 25 years of financial leadership experience across healthcare, life sciences, and technology sectors. His expertise spans corporate finance, strategic planning, capital markets, and investor relations for publicly traded companies. Throughout his career, he has established a consistent record of strengthening financial operations, driving revenue growth, and supporting transformative transactions that enhance shareholder value.
Most recently, Areglado served as Chief Financial Officer of BrainsWay Ltd. (Nasdaq: BWAY), a global medical device leader in interventional psychiatry. In that role, he helped redefine corporate strategy, led eight consecutive quarters of revenue growth, and improved financial discipline and transparency while expanding analyst coverage and investor engagement.
Prior to BrainsWay, Areglado was Chief Financial Officer at iCAD, Inc. (Nasdaq: ICAD), a medical technology company focused on AI-driven cancer detection and therapy solutions. He successfully led financings totaling more than $50 million, executed key strategic partnerships, and supported acquisitions that expanded the company’s market reach and product portfolio.
Earlier in his career, Areglado held senior financial roles at AMICAS, Inc. (Nasdaq: AMCS) and several emerging technology companies, gaining extensive experience in SEC reporting, mergers and acquisitions, and operational transformation. He began his career in public accounting and holds an MBA from Babson College and a BBA in Accounting from the University of Massachusetts Amherst.
“MindWalk represents a unique opportunity to apply data-driven financial leadership in support of an organization poised to redefine how AI is applied in life sciences,” said Areglado. “I am excited to join the team and help advance both our strategic and financial goals as we build long-term value for shareholders.”
